Johnson & Johnson

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About JNJ

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. 

CEO
Joaquin Duato
CEOJoaquin Duato
Employees
140,800
Employees140,800
Headquarters
New Brunswick, New Jersey
HeadquartersNew Brunswick, New Jersey
Founded
1887
Founded1887
Employees
140,800
Employees140,800

JNJ Key Statistics

Market cap
560.32B
Market cap560.32B
Price-Earnings ratio
26.38
Price-Earnings ratio26.38
Dividend yield
2.30%
Dividend yield2.30%
Average volume
7.45M
Average volume7.45M
High today
$235.21
High today$235.21
Low today
$229.00
Low today$229.00
Open price
$230.47
Open price$230.47
Volume
8.03M
Volume8.03M
52 Week high
$251.71
52 Week high$251.71
52 Week low
$149.04
52 Week low$149.04

Stock Snapshot

As of today, Johnson & Johnson(JNJ) shares are valued at $232.46. The company's market cap stands at 560.32B, with a P/E ratio of 26.38 and a dividend yield of 2.3%.

On 2026-06-06, Johnson & Johnson(JNJ) stock traded between a low of $229.00 and a high of $235.21. Shares are currently priced at $232.46, which is +1.5% above the low and -1.2% below the high.

Johnson & Johnson(JNJ) shares are trading with a volume of 8.03M, against a daily average of 7.45M.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

During the past year, Johnson & Johnson(JNJ) stock moved between $149.04 at its lowest and $251.71 at its peak.

JNJ News

Investing.com 5h
J&J beats lawsuit alleging that talc caused three women’s cancer By Reuters - Investing.com

...

J&J beats lawsuit alleging that talc caused three women’s cancer By Reuters - Investing.com
24/7 Wall St. 15h
Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap By Drew Wood Published Jun 5, 9:18AM EDT Quick Read A...

Five Boring Dividend Aristocrats That Quietly Pay $36,000 a Year on $850,000 Without a Single Yield Trap
TipRanks 15h
J&J Oncology Outlook Largely Priced In: Gerberry Reiterates Hold Rating with Unchanged $254 Price Target

Johnson & Johnson, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Jason Gerberry from Bank of America Securities maint...

Analyst ratings

68%

of 25 ratings
Buy
68%
Hold
28%
Sell
4%

More JNJ News

Nasdaq 15h
Can JNJ Sustain Growth Amid Patent, Legal and China Risks?

Johnson & Johnson JNJ faces several challenges, including revenue pressure from upcoming patent expirations, unresolved legal issues related to its talc powder,...

Can JNJ Sustain Growth Amid Patent, Legal and China Risks?
24/7 Wall St. 16h
Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target

Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target By Jeremy Phillips Published Jun 5, 8:19AM EDT Quick Read Johnson & Johnson (JNJ) ra...

Dividend Aristocrats on Sale: 5 Decades-Long Raisers Trading Below Target
24/7 Wall St. 2d
Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200

Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200 By Joel South Published Jun 4, 9:15AM EDT Quick Read Holding O an...

Without a Roth, $60,000 in Dividend Income From These 5 Stocks Means You Owe the IRS $22,200
24/7 Wall St. 2d
Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here’s What It Would Take By Drew Wood Published Jun 4, 6:51AM EDT Quick Read Replac...

Can Pure Dividend Stocks Replace a $110,000 Dual-Income Household Income? Here's What It Would Take
TipRanks 3d
Johnson & Johnson presents exploratory analyses from DAHLIAS study

Johnson & Johnson announced new biomarker exploratory analyses from the Phase 2 DAHLIAS study evaluating nipocalimab in adults with moderate-to-severe Sjogren’s...

Simply Wall St 3d
A Look At Johnson & Johnson Valuation After Recent Share Price Weakness

Advertisement Intro Johnson & Johnson (JNJ) stock has been under pressure recently, with the share price down over the past week, month, and past 3 months, pr...

A Look At Johnson & Johnson Valuation After Recent Share Price Weakness
TipRanks 3d
Johnson & Johnson Rival Medline Stock Sinks on FDA Warning over Production Practices

Medline’s (MDLN) shares dropped about 7% on Tuesday afternoon after the U.S. health watchdog issued a warning letter to the company — a medical supply rival to...

People also own

Based on the portfolios of people who own JNJ. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.